Tiffani Shelton

Melanoma Therapy via Peptide-Targeted α-Radiation

Yubin Miao, Mark D. Hylarides, Darrell R. Fisher et al. · Clinical Cancer Research · 2005 · 134 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Preparation and biological evaluation of 111In-, 177Lu- and 90Y-labeled DOTA analogues conjugated to B72.3

Huma Mohsin, Jonathan Fitzsimmons, Tiffani Shelton et al. · Nuclear Medicine and Biology · 2007 · 42 citations

Pharmacy, Medicinal Chemistry, Pharmacology +13

Radiolanthanide-Labeled Monoclonal Antibody CC49 for Radioimmunotherapy of Cancer:  Biological Comparison of DOTA Conjugates and ¹⁴⁹Pm, ¹⁶⁶Ho, and ¹⁷⁷Lu

Huma Mohsin, Fang Jia, Geethapriya Sivaguru et al. · Bioconjugate Chemistry · 2006 · 39 citations

Medicine, Nuclear Medicine, Oncology +17

Therapeutic Efficacy of a ¹⁷⁷ Lu-Labeled DOTA Conjugated <i>α</i> -Melanocyte-Stimulating Hormone Peptide in a Murine Melanoma-Bearing Mouse Model

Yubin Miao, Tiffani Shelton, Thomas P. Quinn · Cancer Biotherapy and Radiopharmaceuticals · 2007 · 34 citations

Medicine, Oncology, Pharmacology +16

Evaluation of Combined ¹⁷⁷ Lu-DOTA-8-AOC-BBN (7-14)NH ₂ GRP Receptor-Targeted Radiotherapy and Chemotherapy in PC-3 Human Prostate Tumor Cell Xenografted SCID Mice

Christopher V. Johnson, Tiffani Shelton, Charles J. Smith et al. · Cancer Biotherapy and Radiopharmaceuticals · 2006 · 33 citations · Full text

Medicine, Oncology, Pharmacology +14